Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

524
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
524
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

395
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
395
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

2.2K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.2K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

2.9K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
2.9K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

3.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.2K
Intralumenal Vesicles and Multivesicular Bodies01:38

Intralumenal Vesicles and Multivesicular Bodies

5.0K
Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
5.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Anti-correlation of KLRG1 and PD-1 expression in human tumor CD8 T cells.

Oncotargetยท2026
Same author

Compassionate use efficacy of the interferon-beta inhibitor dazukibart in dermatomyositis.

Journal of the European Academy of Dermatology and Venereology : JEADVยท2026
Same author

Web Alert.

Current sports medicine reportsยท2025
Same author

Web Alert.

Current sports medicine reportsยท2025
Same author

Monoclonal antibody targeting IFNฮฒ for the treatment of NXP2-positive ulcerative juvenile dermatomyositis.

Pediatricsยท2025
Same author

Web Alert.

Current sports medicine reportsยท2025
Same journal

Key Considerations in Telestroke Program Management.

Continuum (Minneapolis, Minn.)ยท2026
Same journal

Neurology's Action Potential: Delivering on the Promise of Brain Health.

Continuum (Minneapolis, Minn.)ยท2026
Same journal

Erratum.

Continuum (Minneapolis, Minn.)ยท2026
Same journal

Management of Large Artery Atherosclerosis.

Continuum (Minneapolis, Minn.)ยท2026
Same journal

Thrombolysis, Thrombectomy, and Antithrombotic Therapy for Acute Ischemic Stroke.

Continuum (Minneapolis, Minn.)ยท2026
Same journal

Stroke in Children and Younger Adults.

Continuum (Minneapolis, Minn.)ยท2026
See all related articles

Related Experiment Video

Updated: Mar 10, 2026

Vascular Occlusion Training for Inclusion Body Myositis: A Novel Therapeutic Approach
09:01

Vascular Occlusion Training for Inclusion Body Myositis: A Novel Therapeutic Approach

Published on: June 5, 2010

14.7K

Inclusion Body Myositis.

Steven A Greenberg

    Continuum (Minneapolis, Minn.)
    |December 7, 2016
    PubMed
    Summary
    This summary is machine-generated.

    Inclusion body myositis (IBM) is an autoimmune skeletal muscle disease. New diagnostic markers and understanding of its autoimmune basis are paving the way for effective treatments.

    More Related Videos

    Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
    10:55

    Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

    Published on: October 31, 2025

    956
    Minimally Invasive Muscle Embedding MIME - A Novel Experimental Technique to Facilitate Donor-Cell-Mediated Myogenesis
    09:17

    Minimally Invasive Muscle Embedding MIME - A Novel Experimental Technique to Facilitate Donor-Cell-Mediated Myogenesis

    Published on: August 24, 2017

    8.2K

    Related Experiment Videos

    Last Updated: Mar 10, 2026

    Vascular Occlusion Training for Inclusion Body Myositis: A Novel Therapeutic Approach
    09:01

    Vascular Occlusion Training for Inclusion Body Myositis: A Novel Therapeutic Approach

    Published on: June 5, 2010

    14.7K
    Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
    10:55

    Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

    Published on: October 31, 2025

    956
    Minimally Invasive Muscle Embedding MIME - A Novel Experimental Technique to Facilitate Donor-Cell-Mediated Myogenesis
    09:17

    Minimally Invasive Muscle Embedding MIME - A Novel Experimental Technique to Facilitate Donor-Cell-Mediated Myogenesis

    Published on: August 24, 2017

    8.2K

    Area of Science:

    • Neurology
    • Immunology
    • Muscle Diseases

    Background:

    • Inclusion body myositis (IBM) is a progressive skeletal muscle disorder with unclear causes.
    • Understanding the pathophysiology of IBM is crucial for developing targeted therapies.

    Observation:

    • Diagnostic blood tests for IBM have emerged, linked to a B-cell pathway and autoantibodies against NT5C1A.
    • A connection between IBM and T-cell large granular lymphocytic leukemia highlights the role of cytotoxic T cells.
    • Research diagnostic criteria are being refined for improved accuracy in diagnosing IBM.

    Findings:

    • IBM is increasingly recognized as an autoimmune disease, with identified autoantigens and B-cell pathways.
    • CD8+ T-cell expansions in blood and muscle serve as potential biomarkers for IBM.
    • A mechanistic link between IBM and T-cell large granular lymphocytic leukemia is suggested.

    Implications:

    • Advances in understanding IBM's autoimmune nature are key to developing new treatments.
    • Improved diagnostic accuracy and biomarker identification can enhance patient care for IBM.
    • The high unmet medical need in IBM necessitates continued research into its pathogenesis and therapeutic strategies.